With the ink barely dry on last month’s $417 million award to a California woman who developed ovarian cancer after decades of using Johnson & Johnson’s baby powder products, many are asking if they should join the litigation, and what this could mean for their case.
There’s no shortage of reports finding traces of weed killer RoundUp’s active ingredient glyphosate in some of the most popular consumer staples like cereals, crackers, chips and oatmeal.
More than seven years now since the introduction of novel oral anticoagulant (NOAC) drugs like Pradaxa, Xarelto and Eliquis, experts are still debating their safety relative to warfarin, the drug they were meant to replace.
Yet, despite the billions in sales for these medications, one thing can’t be debated: tens of thousands of patients have already been hospitalized or killed from internal bleeding after taking them.
Over the past week, the FDA has published recalls for six different food products and a popular blood thinner medication in an attempt to protect the public. The dangers range from simple allergens to dangerous bacterial contaminations and improperly dosed drugs.
Glyphosate-based weed killers like RoundUp have become the most widely used in the world, growing 100-fold since their introduction and creating billions in annual sales for chemical giant Monsanto in the process.
However, recent studies suggest this chemical, used by everyone from weekend gardeners to professional landscapers and agriculture workers, may lead to a dangerous form of cancer called non-Hodgkin’s lymphoma.
Every parent knows how stubborn babies can be when it comes to eating, napping on schedule and the ill-fated timing of those, err blowouts.
Last week, the FDA announced recalls for seven food products and two prescription medications due to problems ranging from mislabeling to the presence of bacterial contamination and glass particles
Last year, Stryker-owned Howmedica Osteonics Corp. recalled more than 40,000 of its popular hip replacement implants from the market due to defects in the LFit femoral head that can cause devices to fail, break, or shed metal debris in patients.
However, this is only the latest in a string of recalls by the company of their hip devices for similar problems, and they have already paid more than $1 billion in compensation to those injured.
The shocking reports out last month linking breast implants to a rare form of cancer caught many of us by surprise. After all, with nearly 300,000 women undergoing breast augmentation each year, most of us know someone who’s had an implant procedure.
Anytime a risk of cancer is involved, it should get our full attention. But, as we dig deeper into this latest health alert, we find it isn’t necessarily new and may not pose as great a risk as has been portrayed by the headlines. And, those injured may have legal options.
If you or a loved one are among the more than 250,000 people who undergo heart surgery each year, chances are doctors used a device called a surgical heater-cooler to maintain blood temperature at a constant bodily level during the procedure.
Recently, the FDA and CDC warned that the surgical heater brand used in most heart surgeries each year, the Stockert 3T Heater-Cooler, could subject patients to deadly internal infections.
In December, medical device giant Zimmer Biomet issued what has become a Class-I recall of one of their most popular shoulder implants, the Comprehensive Reverse Shoulder. However, the company did so without notifying the thousands of patients that had received the devices.
Now, many are questioning the company’s handling of the recall, and asking if Zimmer could have done more to protect patients from potential implant failures and the need for painful revision surgery.